RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform ...
Flu season is in full force in the United States. At least 310,000 flu-related hospitalizations and 13,000 deaths have been ...
Leerink Partnrs upgraded shares of CVS Health (NYSE:CVS – Free Report) from a hold rating to a strong-buy rating in a ...
Millions of people fall ill with the flu every year, and adults age 65 and older are at higher risk of developing serious ...
CVS (CVS) reported fourth quarter and full-year 2024 earnings Wednesday, beating Wall Street's expectations and sending its stock up 15% for the day. Full-year revenue came in at $372.8 billion, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results